{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:55:13Z","timestamp":1790668513504,"version":"4.1.0"},"reference-count":27,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3724\/abbs.2026169","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:44:51Z","timestamp":1789695891000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer"],"prefix":"10.3724","author":[{"given":"Shanshan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Xiahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"113345","DOI":"10.1016\/j.biopha.2022.113345","volume":"153","author":"Bhattacharjee R","year":"2022","unstructured":"Bhattacharjee R, Dey T, Kumar L, Kar S, Sarkar R, Ghorai M, Malik S. Cellular landscaping of cisplatin resistance in cervical cancer. Biomed Pharmacother, 2022, 153:","journal-title":"Biomed Pharmacother"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3724\/abbs.2024009","volume":"56","author":"Jin S","year":"2024","unstructured":"Jin S, Wang W, Xu X, Yu Z, Feng Z, Xie J, Lv H. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer. Acta Biochim Biophys Sin, 2024, 56: 740-752.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12935-021-02239-6","volume":"21","author":"Lv H","year":"2021","unstructured":"Lv H, Jin S, Zou B, Liang Y, Xie J, Wu S. Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance. Cancer Cell Int, 2021, 21:","journal-title":"Cancer Cell Int"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3724\/abbs.2025032","volume":"57","author":"Wang B","year":"2025","unstructured":"Wang B, Li L, Wu Z, Qian X, Yu W, Huang Z. Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p\/IKBKB axis. Acta Biochim Biophys Sin, 2025, 57: 1492-1506.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Tan Y","year":"2022","unstructured":"Tan Y, Li J, Zhao G, Huang KC, Cardenas H, Wang Y, Matei D. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun, 2022, 13:","journal-title":"Nat Commun"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"Icard P","year":"2018","unstructured":"Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?. Drug Resist Updat, 2018, 38: 1-11.","journal-title":"Drug Resist Updat"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","volume":"81","author":"Sun Y","year":"2025","unstructured":"Sun Y, Wang H, Cui Z, Yu T, Song Y, Gao H, Tang R. Lactylation in cancer progression and drug resistance. Drug Resist Updat, 2025, 81:","journal-title":"Drug Resist Updat"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"110149","DOI":"10.1016\/j.abb.2024.110149","volume":"761","author":"Li D","year":"2024","unstructured":"Li D, Xiong Y, Li M, Long L, Zhang Y, Yan H, Xiang H. STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K\/Akt\/mTOR pathway. Arch Biochem Biophys, 2024, 761:","journal-title":"Arch Biochem Biophys"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11011-025-01571-4","volume":"40","author":"Wei Z","year":"2025","unstructured":"Wei Z, Ge D, Bu J, Wang X, Zhong T, Gongye X, Zhang B. STC2 regulates the proliferation, migration and glycolysis of glioma cells through modulating ITGB2. Metab Brain Dis, 2025, 40:","journal-title":"Metab Brain Dis"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10565-021-09600-5","volume":"38","author":"Li J","year":"2022","unstructured":"Li J, Zhang Z, Feng X, Shen Z, Sun J, Zhang X, Bu F. Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2\/FAK\/SOX6 signaling pathway in nasopharyngeal carcinoma. Cell Biol Toxicol, 2022, 38: 259-272.","journal-title":"Cell Biol Toxicol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cac2.12274","volume":"42","author":"Wang Z","year":"2022","unstructured":"Wang Z, Chen W, Zuo L, Xu M, Wu Y, Huang J, Zhang X. The fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun, 2022, 42: 245-265.","journal-title":"Cancer Commun"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","volume":"68","author":"Ye L","year":"2022","unstructured":"Ye L, Jiang Y, Zhang M. Crosstalk between glucose metabolism, lactate production and immune response modulation. Cytokine Growth Factor Rev, 2022, 68: 81-92.","journal-title":"Cytokine Growth Factor Rev"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","volume":"404","author":"McCormack M","year":"2024","unstructured":"McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, Hudson E. Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial. Lancet, 2024, 404: 1525-1535.","journal-title":"Lancet"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41467-019-08290-2","volume":"10","author":"Yimit A","year":"2019","unstructured":"Yimit A, Adebali O, Sancar A, Jiang Y. Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs. Nat Commun, 2019, 10:","journal-title":"Nat Commun"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"100900","DOI":"10.1016\/j.currproblcancer.2022.100900","volume":"46","author":"Kumar L","year":"2022","unstructured":"Kumar L, Upadhyay A, Jayaraj AS. Chemotherapy and immune check point inhibitors in the management of cervical cancer. Curr Probl Cancer, 2022, 46:","journal-title":"Curr Probl Cancer"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3724\/abbs.2025048","volume":"57","author":"Chen T","year":"2025","unstructured":"Chen T, Xu Y, Yang K, Du Y, Zhu Z, Xu L, Wang X. Withaferin A combined with ricolinostat: a potent synergistic therapy for cervical cancer through regulating p53 ubiquitination and acetylation. Acta Biochim Biophys Sin, 2025, 57: 2133-2136.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"Vander Heiden MG","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324: 1029-1033.","journal-title":"Science"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/ijms24032606","volume":"24","author":"Chelakkot C","year":"2023","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating glycolysis to improve cancer therapy. Int J Mol Sci, 2023, 24:","journal-title":"Int J Mol Sci"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3389\/fonc.2019.01536","volume":"9","author":"San-Mill\u00e1n I","year":"2020","unstructured":"San-Mill\u00e1n I, Julian CG, Matarazzo C, Martinez J, Brooks GA. Is lactate an oncometabolite? Evidence supporting a role for lactate in the regulation of transcriptional activity of cancer-related genes in MCF7 breast cancer cells. Front Oncol, 2020, 9:","journal-title":"Front Oncol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"Zhang D","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W. Metabolic regulation of gene expression by histone lactylation. Nature, 2019, 574: 575-580.","journal-title":"Nature"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"107017","DOI":"10.1016\/j.phrs.2023.107017","volume":"198","author":"Liu S","year":"2023","unstructured":"Liu S, Yue S, Guo Y, Han JY, Wang H. Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes. Pharmacol Res, 2023, 198:","journal-title":"Pharmacol Res"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41419-024-06610-z","volume":"15","author":"Tran TTT","year":"2024","unstructured":"Tran TTT, Hung JJ. PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFRL858R-induced lung cancer progression. Cell Death Dis, 2024, 15:","journal-title":"Cell Death Dis"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41598-022-27273-w","volume":"13","author":"Yao J","year":"2023","unstructured":"Yao J, Ding Y, Liu X, Huang J, Zhang M, Zhang Y, Lv Y. Application value of whole exome sequencing in screening and identifying novel mutations of hypopharyngeal cancer. Sci Rep, 2023, 13:","journal-title":"Sci Rep"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41598-021-04664-z","volume":"12","author":"Cava C","year":"2022","unstructured":"Cava C, Armaos A, Lang B, Tartaglia GG, Castiglioni I. Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes. Sci Rep, 2022, 12:","journal-title":"Sci Rep"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12864-024-10295-1","volume":"25","author":"Schmit SL","year":"2024","unstructured":"Schmit SL, Tsai YY, Bonner JD, Sanz-Pamplona R, Joshi AD, Ugai T, Lindsey SS. Germline genetic regulation of the colorectal tumor immune microenvironment. BMC Genomics, 2024, 25:","journal-title":"BMC Genomics"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3724\/abbs.2025022","volume":"57","author":"Xu A","year":"2025","unstructured":"Xu A, Yang X, Zhao J, Kong S, Tang Q, Li X, Qu H. KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer. Acta Biochim Biophys Sin, 2025, 57: 1517-1528.","journal-title":"Acta Biochim Biophys Sin"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/9057B2CF7E56476F90510C87C6669B5B","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/9057B2CF7E56476F90510C87C6669B5B","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:02:16Z","timestamp":1790665336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026169","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}